NCT01917006 - A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 7, 2013

Primary Completion Date

August 15, 2017

Study Completion Date

August 15, 2017

Conditions

Premature Ejaculation

Interventions

DRUG

OnabotulinumtoxinA

OnabotulinumtoxinA injected into specified muscle per protocol on Day 1.

DRUG

Normal Saline

Placebo (normal saline) injected into specified muscle per protocol on Day 1.

Trial Locations (10)

Manhattan Medical Research, New York

Center for Marital and Sexual Health of South Florida, West Palm Beach

Tulane University School of Medicine, New Orleans

LA Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance

San Diego Sexual Medicine, San Diego

Connecticut Clinical Research Center, Middlebury

Celerion, Belfast

King's College Hospital, London

Queen Anne Street Medical Center, London

St Mary's Hospital, London